Lv31
380 积分 2025-04-17 加入
The landscape for therapeutic cancer vaccines
9分钟前
待确认
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
3天前
已完结
Durvalumab, Tremelimumab, and Enfortumab Vedotin in Muscle-Invasive Bladder Cancer
3天前
已完结
Sensitive quantitative IgD assay increases progression-free survival prediction accuracy in IgD plasma cell myeloma
18天前
已完结
Safety and efficacy of nipocalimab in adults with generalised myasthenia gravis (Vivacity-MG3): a phase 3, randomised, double-blind, placebo-controlled study
20天前
已完结
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
20天前
已完结
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
26天前
已完结
Understanding the therapeutic toolkit for inflammatory bowel disease
26天前
已完结
Daratumumab for maintenance in myeloma
29天前
已完结
Measurable Residual Disease–Guided Therapy in Newly Diagnosed Myeloma
29天前
已完结